½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

<ar id='pyxprs'></ar>
»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹CLN6¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹CLN6¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW14914
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·


ÖÐÎÄÃû³Æ£ºÍÿ¹CLN6¶à¿Ë¡¿¹Ìå   

Ó¢ÎÄÃû³Æ£ºAnti-CLN6 rabbit polyclonal antibody

±ð      Ãû£ºnclf; CLN4A; HsT18960

¿¹      Ô­£ºCLN6

´¢      ´æ£ºÀä¶³£¨-20¡æ£© ±Ü¹â

ËÞ      Ö÷£ºRabbit

·´Ó¦ÖÖÊô£ºHuman

Ïà¹ØÀà±ð£ºÒ»¿¹

±ê ¼Ç ÎUnconjugate

¿Ë¡ÀàÐÍ£ºUnconjugate

¼¼Êõ¹æ¸ñ

Background:

This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.

Applications:

WB, IHC

Name of antibody:

CLN6

Immunogen:

Synthesized peptide derived from internal of human CLN6.

Full name:

ceroid-lipofuscinosis, neuronal 6, late infantile, variant

Synonyms£º

nclf; CLN4A; HsT18960

SwissProt:

Q9NWW5

IHC positive control:

Human cervix tissue

IHC Recommend dilution:

50-100

WB Predicted band size:

36 kDa

WB Positive control:

Hela cells lysate

WB Recommended dilution:

500-3000





¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿